Indiana bills · 2026 Regular Session
Indiana SB 157
Disclosures related to prescription drugs.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Lori Goss-Reaves (Republican)
- Michael Crider (Republican)
- Mike Bohacek (Republican)
Cosponsors (3)
- Brad Barrett (Republican)
- Lonnie Randolph (Democratic)
- La Keisha Jackson (Democratic)
Summary
Official abstract published by the Indiana legislature· Digest
Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 8:04 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Jan 26, 2026 Senate | SB 157 - Bohacek - 3rd Reading | pass | Set your home in Indiana to see |
Actions
- Jan 28, 2026 · House
First reading: referred to Committee on Public Health - Jan 27, 2026 · Senate
Referred to the House - Jan 26, 2026 · Senate
Cosponsor: Representative Barrett - Jan 26, 2026 · Senate
House sponsor: Representative Goss-Reaves - Jan 26, 2026 · Senate
Senator Crider added as second author - Jan 26, 2026 · Senate
Third reading: passed; Roll Call 72: yeas 44, nays 0 - Jan 22, 2026 · Senate
Amendment #1 (Bohacek) prevailed; voice vote - Jan 22, 2026 · Senate
Second reading: amended, ordered engrossed - Jan 15, 2026 · Senate
Committee report: amend do pass, adopted - Jan 15, 2026 · Senate
Senator Randolph added as coauthor - Jan 6, 2026 · Senate
Senator Jackson L added as coauthor - Jan 5, 2026 · Senate
Authored by Senator Bohacek - Jan 5, 2026 · Senate
First reading: referred to Committee on Insurance and Financial Institutions